HOME
ABOUT US
Company Profile
Honor
Public welfare undertakings
NEWS & INFORMATION
Company News
Frontiers of Medicine
Product Information
PRODUCTS
Huaier Granules
Huaiqihuang (HQH) Granule
Functional Characteristics
Overview of Ongoing Research Projects
RESEARCH MATERIALS
Member Download
Public Information
CONTACT
中文版
English
Medical Frontiers
Huaier Granules, Huaiqi Yellow Granules Product Logo-Copyright Certificate
13
2020
/
08
Notifications
27
07
Interpretation of the latest version of the "liver cancer diagnosis and treatment norms", the anti-cancer effect of traditional Chinese medicine has been approved by foreign scholars!
14
04
Letter on Doing a Good Job in Linking New and Old Charity Assistance Models of Huaier Granules
Dear Jiangsu, Shandong, Hunan, Chongqing and other four patients: On October 8, 2019, the China Charity Federation and Qidong Gaitianli Pharmaceutical Co., Ltd. signed the "Huaier Granule Patient Assistance Project Cooperation Agreement".
03
Warmly congratulate Huaier Granule on its re-inclusion in the 2019 edition of "Standard for Diagnosis and Treatment of Primary Liver Cancer"-Level 1 evidence shows that Huaier Granule treatment after hepatectomy can reduce recurrence and prolong survival.
On December 7, at the 17th National Conference on Liver Cancer, the National Health Commission officially released the "Guidelines for Diagnosis and Treatment of Primary Liver Cancer (2019 Edition)".
2019
12
Huaiqihuang Granules for the Treatment of CKD3 Primary Glomerulonephritis Initiated Meeting Held in Dalian
On the morning of December 7, 2019, the first affiliated Hospital of Dalian Medical University sponsored the "randomized double-blind double-simulation, positive parallel controlled multicenter clinical study of Huaiqihuang Granules in the treatment of CKD3 primary glomerulonephritis" held in Shangri-La Hotel, Dalian, which is the highest level of evidence-based medicine for Huaiqihuang Granules in the treatment of primary glomerulonephritis.
The launching ceremony of "Huaier Granules Patient Assistance Project" was held in Taiyuan. Gong Puguang, vice chairman of the Social Construction Committee of the 13th National people's Congress and president of the China Charity Federation, delivered a speech and announced the launch of the project.
On November 12, the launching ceremony of "Huaier granule patient assistance project" of China Charity Federation was held in Taiyuan City, Shanxi Province. Gong Puguang, vice chairman of the Social Construction Committee of the 13th National people's Congress and president of the China Charity Federation, Xu Wuwei, chairman and general manager of Qidong Gaitianli Pharmaceutical Co., Ltd., and Bian Zhiwei, secretary general of the China Charity Federation, attended the launching ceremony.
11
Heavy! Treatment of bronchial asthma in children have a new choice!
At the 28th National Academic Forum on Childhood Asthma and Allergy Diseases held on April 20, 2019, Professor Liu Chuanhe from the Children's Hospital of the Capital Institute of Pediatrics discussed the real-world research on the effectiveness of Huaiqihuang Granules in the treatment of childhood bronchial asthma. The statistical results were grandly released.
23